These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 19564575)
1. The functional significance behind expressing two IL-8 receptor types on PMN. Stillie R; Farooq SM; Gordon JR; Stadnyk AW J Leukoc Biol; 2009 Sep; 86(3):529-43. PubMed ID: 19564575 [TBL] [Abstract][Full Text] [Related]
2. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6. Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666 [TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a new interleukin-8 receptor in bovine species. Lahouassa H; Rainard P; Caraty A; Riollet C Mol Immunol; 2008 Feb; 45(4):1153-64. PubMed ID: 17727952 [TBL] [Abstract][Full Text] [Related]
4. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513 [TBL] [Abstract][Full Text] [Related]
5. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Feniger-Barish R; Ran M; Zaslaver A; Ben-Baruch A Cytokine; 1999 Dec; 11(12):996-1009. PubMed ID: 10623425 [TBL] [Abstract][Full Text] [Related]
6. Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patients. Mintz R; Garty BZ; Meshel T; Marcus N; Katanov C; Cohen-Hillel E; Ben-Baruch A Immunol Lett; 2010 May; 130(1-2):97-106. PubMed ID: 20005258 [TBL] [Abstract][Full Text] [Related]
7. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2. de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist. Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166 [TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinases. Matityahu E; Feniger-Barish R; Meshel T; Zaslaver A; Ben-Baruch A Eur J Immunol; 2002 Dec; 32(12):3525-35. PubMed ID: 12442335 [TBL] [Abstract][Full Text] [Related]
10. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046 [TBL] [Abstract][Full Text] [Related]
11. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. Chakrabarti S; Patel KD J Leukoc Biol; 2005 Jul; 78(1):279-88. PubMed ID: 15831558 [TBL] [Abstract][Full Text] [Related]
12. Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. Rittner HL; Labuz D; Schaefer M; Mousa SA; Schulz S; Schäfer M; Stein C; Brack A FASEB J; 2006 Dec; 20(14):2627-9. PubMed ID: 17060402 [TBL] [Abstract][Full Text] [Related]
13. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203 [TBL] [Abstract][Full Text] [Related]
16. Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus. Hsieh SC; Wu TH; Tsai CY; Li KJ; Lu MC; Wu CH; Yu CL Rheumatology (Oxford); 2008 Feb; 47(2):150-7. PubMed ID: 18208820 [TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms in the coding regions of human CXC-chemokine receptors CXCR1, CXCR2 and CXCR3. Kato H; Tsuchiya N; Tokunaga K Genes Immun; 2000 Jun; 1(5):330-7. PubMed ID: 11196695 [TBL] [Abstract][Full Text] [Related]
18. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat. Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761 [TBL] [Abstract][Full Text] [Related]
19. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2. Zaslaver A; Feniger-Barish R; Ben-Baruch A J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710 [TBL] [Abstract][Full Text] [Related]
20. Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2. Ramirez BL; Howard OM; Dong HF; Edamatsu T; Gao P; Hartlein M; Kron M J Infect Dis; 2006 Apr; 193(8):1164-71. PubMed ID: 16544258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]